BIIB Financial Facts
Diluted earnings per share attributable to Biogen Idec Inc.: 4.71Product: 2.54B
See Full Income Statement
Commitments and contingencies (Notes 2, 11, 16, 18 and 20): 0
Retained earnings: 15.03B
See Full Balance Sheet
Biogen Idec Inc. (BIIB) Earnings
|
Expand Research on BIIB
Next EPS Date | 4/24/24 | EPS Growth Rate | +2.1% |
---|---|---|---|
Average EPS % Beat Rate | +3.0% | Revenue Growth Rate | -5.7% |
Average % Move 1-Wk after EPS | -3.8% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
4/24/24 | Q124 | N/A | $3.47 | N/A | N/A | $2.32B | = | N/A | N/A | ||
2/13/24 | Q423 | $2.95 | $3.18 | -$0.23 | $2.4B | $2.47B | = | Details | |||
11/8/23 | Q323 | $4.36 | $3.99 | +$0.37 | $2.53B | $2.39B | = | Details | |||
7/25/23 | Q223 | $4.02 | $3.78 | +$0.24 | $2.46B | $2.37B | = | Details | |||
4/25/23 | Q123 | $3.40 | $3.28 | +$0.12 | $2.46B | $2.34B | = | Details | |||
2/15/23 | Q422 | $4.05 | $3.48 | +$0.57 | $2.54B | $2.44B | = | Details | |||
10/25/22 | Q322 | $4.77 | $4.14 | +$0.63 | $2.51B | $2.47B | = | Details | |||
7/20/22 | Q222 | $5.25 | $4.13 | +$1.12 | $2.59B | $2.49B | = | Details |